Target Expands Hemp THC Drink Sales to 300 Stores Despite Looming Federal Ban

Target has announced a major expansion of its intoxicating hemp THC beverage program, rolling out the product line to more than 300 stores across Florida, Texas, and select Illinois locations. This move comes just six months ahead of a federal ban that could remove most of these products from shelves, raising questions about the retailer's strategy and expectations. Brands now available in these stores include Cann, Wynk, Trail Magic, Stigma, Gigli, and Daizy’s, following a successful pilot in Minneapolis and a recent expansion in Minnesota

The timing of Target’s decision is particularly striking given a provision in the federal spending bill set to take effect on November 13, 2026. This provision will redefine legal hemp products, capping them at 0.4 milligrams of total THC per container—far less than what most of Target’s newly stocked beverages contain. According to High Times, "Either Target’s government affairs team knows something the rest of the industry doesn’t, or the math works even if the ban hits. Either answer is news."

Industry analysts suggest that Target may be hedging its bets by preparing to discount its hemp beverage inventory in October if no regulatory resolution emerges. For a company with nearly $107 billion in annual revenue, even a sizable inventory write-down would be financially insignificant, representing just 0.009% of yearly sales. The upside for Target includes collecting valuable consumer data, building supplier relationships, and claiming shelf space in a potentially fast-growing category

The retailer’s move aligns with broader market trends, as other major chains like Sprouts Farmers Market and Circle K have also introduced hemp THC drinks in states where they are permitted. Beverage alcohol distributors are joining the category as well, reflecting a cautious optimism that the impending federal ban may be delayed, softened, or potentially overturned. The current lobbying climate suggests that while the House passed the Farm Bill with the ban language intact, industry pressure to amend or postpone the effective date remains high

A key point of contention is the stark regulatory and tax disparity between mainstream retailers and licensed cannabis dispensaries. As High Times notes, "Same drug. Same effect. Same consumer. Two completely different regulatory pathways, two completely different tax regimes, two completely different economic outcomes. Target is exploiting the gap." While Target enjoys standard corporate tax treatment, dispensaries face punitive rates under IRS Section 280E, which severely limits deductions and inflates effective tax burdens up to 80%

From the OG Lab newsroom perspective, Target’s bold expansion signals both the volatility and the opportunity in the hemp-derived THC beverage sector. This development highlights the urgent need for regulatory and tax equity in the cannabis industry, especially as mainstream retailers capitalize on legal ambiguities. As Congress debates the future of hemp and cannabis regulation, the decisions made in the coming months could fundamentally reshape the competitive landscape for both retailers and licensed operators